0

No More Monkeys Jumping On This Bed: Few Psych Meds Coming Our Way

There’s nothing wrong with the size of the field. The National Institute of Mental Health estimates that nearly one in four adults in America suffers from a diagnosable mental order in any given year. And there’s not been much to… Continue Reading

0

Three Biggest Pharmaceutical Lawsuits of 2012: Psychiatric Drugs Focus of All Three

“A billion here, a billion there, sooner or later it adds up to real money.” ~ Everett Dirksen, Congressman What Senator Dirksen knew about government spending is these days being applied to drug company fines. And it seems these penalties… Continue Reading

0

Breaking News: GlaxoSmithKline to Plead Guilty Over Marketing of Antidepressants

Today, I am pleased to announce that the Justice Department and our law enforcement partners have reached an historic $3 billion resolution with the pharmaceutical manufacturer GlaxoSmithKline, LLC, to resolve multiple investigations into the company’s sales, marketing, and pricing practices.… Continue Reading